Atinum Investment Co., Ltd

Equities

A021080

KR7021080007

Investment Management & Fund Operators

End-of-day quote Korea S.E. Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
2,690 ^KRW	-2.54%		-5.61%	-24.97%

06-19	IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments	MT
05-13	MedInTech Inc. announced that it has received KRW 20 billion in funding from a group of investors	CI

MedInTech Inc. announced that it has received KRW 20 billion in funding from a group of investors

May 12, 2024

MedInTech Inc. announced that it has raised KRW 20 billion in a round of funding on May 13, 2024. The transaction included participation from new investors Samchully Investment Co., Ltd., Hana Ventures Inc., Wooshin Venture Investment Corp., SL Investment, Industrial Bank of Korea, returning investors Nextrans, FuturePlay Inc., Smilegate Investment, Inc and Atinum Investment Co., Ltd. The company has received KRW 28 billion in funding till date.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	INDUSTRIAL BANK OF KOREA	13,500 KRW	-0.44%	+0.97%	7.74B
	ATINUM INVESTMENT CO., LTD	2,690 KRW	-2.54%	-5.61%	90.94M

Latest news about Atinum Investment Co., Ltd

IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments	06-19	MT
MedInTech Inc. announced that it has received KRW 20 billion in funding from a group of investors	05-12	CI
I-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd	04-29	CI
Modusign Inc announced that it has received KRW 17.7 billion in funding from SBVA, Atinum Investment Co., Ltd, Industrial Bank of Korea, DSC Investment Inc.	04-28	CI
I-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd	04-25	CI
Bria AI announced that it has received $24 million in funding from a group of investors	02-20	CI
DAAN Bio Therapeutics announced that it has received KRW 23 billion in funding from a group of investors	01-28	CI
Klook Travel Technology Limited announced that it has received $210 million in funding from a group of investors	12-05	CI
Klook Travel Technology Limited announced that it has received $210 million in funding from a group of investors	12-05	CI
Allganize, Inc. announced that it has received $20.2 million in funding from a group of investors	12-03	CI
Openedges Square Co., Ltd. announced that it has received KRW 18 billion in funding from Atinum Investment Co., Ltd, Stonebridge Ventures Inc.	11-09	CI
Openedges Square Co., Ltd. announced that it expects to receive KRW 18 billion in funding from Atinum Investment Co., Ltd, Stonebridge Ventures Inc.	30/10/23	CI
Bruker Corporation completed the acquisition of PhenomeX Inc..	28/09/23	CI
Tranche Update on Atinum Investment Co., Ltd's Equity Buyback Plan announced on March 20, 2023.	20/09/23	CI
Tranche Update on Atinum Investment Co., Ltd's Equity Buyback Plan announced on March 20, 2023.	20/09/23	CI
Atinum Investment Co., Ltd's Equity Buyback announced on March 20, 2023, has expired with 1,000,000 shares, representing 2.14% for KRW 2,708.43 million.	19/09/23	CI
Atinum Investment Co., Ltd(KOSDAQ:A021080) dropped from S&P Global BMI Index	18/09/23	CI
Bruker Corporation signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc..	16/08/23	CI
Rapport Labs announced that it has received KRW 34 billion in funding from Kakao Ventures Corp., Altos Ventures Management, Inc., Atinum Investment Co., Ltd	03/08/23	CI
IMBiologics Inc. announced that it has received KRW 20 billion in funding from a group of investors	23/07/23	CI
CryptoQuant Inc. announced that it has received KRW 8.5 billion in funding from Atinum Investment Co., Ltd, IMM Investment, Corp., SK Group Ltd., Bass Investment Corp., HillSpring Investment	05/07/23	CI
Tranche Update on Atinum Investment Co., Ltd's Equity Buyback Plan announced on March 20, 2023.	22/06/23	CI
XL8 Inc. announced that it has received $10.965528 million in funding from KB Investment Co., Ltd., Atinum Investment Co., Ltd and other investors	17/05/23	CI
Glassdome, Inc. announced that it has received $8.6 million in funding from Atinum Investment Co., Ltd, Primer Sazze Partners, Murex Investments, Dunamu & Partners, CRIT VENTURES Inc. and another investor	16/05/23	CI
XL8 Inc. announced that it expects to receive $13.453128 million in funding	02/05/23	CI

Chart Atinum Investment Co., Ltd

Duration

Period

More charts

Company Profile

Atinum Investment Co., Ltd is a Korea-based company principally engaged in the venture investment business. It mainly invests in information technology (IT) and communication, renewable and energy, bio and life science, materials and components, as well as media and contents industries. The Companyâs principal activities consist of venture support services, including the consulting of foundation procedures, start-up capital support procedures, tax and accounting, and government support policies; support services for its investment companies including business consulting services of technology trends, strategy plans, human resource plans, initial public offerings (IPOs), restructurings, mergers and acquisitions (M&As), market information and others, and international supports services such as overseas corporation investments as well as cooperative mutual investments of domestic and overseas corporations.

Sector

Investment Management & Fund Operators

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Venture Capital

	1st Jan change	Capi.
ATINUM INVESTMENT CO., LTD	-24.97%	90.94M
HERCULES CAPITAL, INC.	+18.90%	3.17B
UMBRA COMPANIES INC.	+12.50%	1.76B
HBM HEALTHCARE INVESTMENTS AG	+13.64%	1.59B
OCTOPUS TITAN VCT PLC	-11.54%	1.22B
MOLTEN VENTURES PLC	+45.71%	960M
VERUSA HOLDING	+49.75%	629M
OCTOPUS APOLLO VCT PLC	-4.17%	502M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+26.09%	455M
GOZDE GIRISIM SERMAYESI YATIRIM ORTAKLIGI	+35.64%	331M

Venture Capital